Company Analysis

MediWound Ltd. (MDWD)

Nasdaq: MDWD · Medicinal Chemicals & Botanical Products · Yavne, IL · filing with the SEC since 2013
Grade3.8
◀ Past 5.1● Present 2.7▶ Future 3.9
2 est.

Who runs MediWound Ltd.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Gonen Ofer
Chief Executive Officer. First filing Mar 2026, latest Nov 12, 2026, 0 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
11 people on the record since 2026
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Gonen OferChief Executive OfficerMar 2026Nov 12, 2026none
Hess ShmuelCOO & Chief Commercial OfficerMar 2026Aug 28, 20263 · $100,000
Luxenburg Kalfon HanaChief Financial OfficerMar 2026Mar 18, 2026none
Klinger EtyChief Medical OfficerMar 2026Mar 18, 2026none
Ben Yaakov AyaVP Clinical & Reg. AffairsMar 2026Mar 18, 2026none
Meyer YaronEVP, GC & Corp. SecretaryMar 2026Mar 18, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Fox David MortondirectorMar 2026Nov 12, 2026none
Shamir NachumdirectorMar 2026Nov 12, 2026none
Rubinstein SamueldirectorMar 2026Sep 2, 20261 · $0.00
Driver Vickie RaedirectorMar 2026Mar 25, 2026none
Wills Stephen TdirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MDWD · research, not advice